Lenz & Staehelin and Freshfields advised Baloise on the deal. Walder Wyss and Clifford Chance advised Helvetia. Baloise Holding Ltd and Helvetia Holding Ltd have announced...
Helvetia AG’s Merger With Baloise AG
Alentis Therapeutics’ $181.4 Million Series D Financing Round
Walder Wyss advised Alentis Therapeutics on the deal. Honigman advised Catalio Capital Management. Alentis Therapeutics raised $181.4 million in Series D financing, supported by a syndicate...
GEODIS’ Acquisition of ITS – International Transport & Shipping Ltd.
Walder Wyss advised the ITS shareholders in this transaction. GEODIS, one of the world’s leading transport and logistics companies, has acquired Swiss freight forwarder ITS –...
Alentis Therapeutics’ $105 Million Series C Funding Round
Walder Wyss advises Alentis Therapeutics on the financing. Alentis Therapeutics has announced $105 million in Series C financing. The funding round was led by Jeito Capital...
Distalmotion SA’s $90 Million Series E Financing Round
Walder Wyss advised Distalmotion in connection with the transaction. Bär & Karrer advised Revival Healthcare Capital alongside Wilson Sonsini in this transaction. Distalmotion SA, a young,...
Cawood Scientific’s Acquisition of Innovative Environmental Services (IES)
Bär & Karrer acted as legal advisor to Cawood Scientific. Walder Wyss advised IES’ shareholders in this transaction. Cawood Scientific, UK’s leading independent scientific group, announced...






























